Loading insider details...
Beta
Latest Form 4 (May 7, 2026): Grant/Award of 100,000 ARCT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 7, 2026 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/Award | 100,000 | n/a |
| Jan 10, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 6,700 | n/a |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 5,245 | n/a |
| Jan 7, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 8,292 | n/a |
| Dec 23, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 10,000 | $201.6K |
| Dec 18, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 10,000 | $201.6K |
| Jan 7, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 8,293 | n/a |
| Sep 17, 2024 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 6,000 | n/a |
| Jul 24, 2024 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 20,000 | n/a |
| May 24, 2024 | ANAPTYSBIO, INC (ANAB) | Sale | 1,500 | $35.6K |